JAZZ

Jazz Pharmaceuticals plcNASDAQHealthcare

$186.95-0.70%ClosedMarket Cap: $11.51B

As of 2026-04-06

Recent Analyst Ratings

Date	Firm	Action	Rating	Previous
2026-03-19	Piper Sandler	—	Overweight	—
2026-02-25	Morgan Stanley	—	Overweight	—
2026-02-25	B of A Securities	—	Buy	—
2026-02-25	Wells Fargo	—	Overweight	—
2026-02-25	RBC Capital	—	Outperform	—
2026-01-12	Truist Securities	—	Buy	—
2026-01-12	Needham	—	Buy	—
2025-12-10	Piper Sandler	—	Overweight	—
2025-11-24	UBS	—	Neutral	—
2025-11-18	Baird	—	Outperform	—

Forward Estimates

Period	EPS Est.	Revenue Est.	# Analysts
Fri Dec 31	$25.01	$4.79B	10
Sun Dec 31	$26.70	$5.18B	4
Mon Dec 31	$30.88	$5.76B	2
Tue Dec 31	$31.98	$6.02B	2